Bone metastases of unknown origin: epidemiology and principles of management

Andrea Piccioli, Giulio Maccauro, Maria Silvia Spinelli, Roberto Biagini, Barbara Rossi

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Abstract: Metastases are the most common malignancies involving bone; breast, prostate, lung and thyroid are the main sites of primary cancer. However, up to 30 % of patients present with bone metastases of unknown origin, where the site of the primary neoplasm cannot be identified at the time of diagnosis despite a thorough history, physical examination, appropriate laboratory testing and modern imaging technology (CT, MRI, PET). Sometimes only extensive histopathological investigations on bone specimens from biopsy can suggest the primary malignancy. At other times, a bone lesion can have such a highly undifferentiated histological appearance that a precise pathological classification on routine hematoxylin–eosin-stained section is not possible. The authors reviewed the relevant literature in an attempt to investigate the epidemiology of the histological primaries finally identified in patients with bone metastases from occult cancer, and a strategy of management and treatment of bone metastases from occult carcinomas is suggested. Lung, liver, pancreas and gastrointestinal tract are common sites for primary occult tumors. Adenocarcinoma is the main histological type, accounting for 70 % of all cases, while undifferentiated cancer accounts for 20 %. Over the past 30 years, lung cancer is the main causative occult primary for bone metastases and has a poor prognosis with an average survival of 4–8 months. Most relevant literature focuses on the need for standardized diagnostic workup, as surgery for bone lesions should be aggressive only when they are solitary and/or the occult primaries have a good prognosis; in these cases, identification of the primary tumor may be important and warrants special diagnostic efforts. However, in most cases, the primary site remains unknown, even after autopsy. Thus, orthopedic surgery has a mainly palliative role in preventing or stabilizing pathological fractures, relieving pain and facilitating the care of the patient in an attempt to provide the most appropriate therapy for the primary tumor as soon as possible. Level of evidence: 5

Original languageEnglish
Article number344
Pages (from-to)81-86
Number of pages6
JournalJournal of Orthopaedics and Traumatology
Volume16
Issue number2
DOIs
Publication statusPublished - Mar 1 2015

Fingerprint

Epidemiology
Neoplasm Metastasis
Bone and Bones
Neoplasms
Neoplasms by Site
Lung
Spontaneous Fractures
Physical Examination
Orthopedics
Gastrointestinal Tract
Prostate
Pancreas
Autopsy
Lung Neoplasms
Patient Care
Thyroid Gland
Adenocarcinoma
Breast
History
Technology

Keywords

  • Bone metastases
  • Carcinoma
  • Unknown origin

ASJC Scopus subject areas

  • Surgery
  • Orthopedics and Sports Medicine

Cite this

Bone metastases of unknown origin : epidemiology and principles of management. / Piccioli, Andrea; Maccauro, Giulio; Spinelli, Maria Silvia; Biagini, Roberto; Rossi, Barbara.

In: Journal of Orthopaedics and Traumatology, Vol. 16, No. 2, 344, 01.03.2015, p. 81-86.

Research output: Contribution to journalArticle

Piccioli, Andrea ; Maccauro, Giulio ; Spinelli, Maria Silvia ; Biagini, Roberto ; Rossi, Barbara. / Bone metastases of unknown origin : epidemiology and principles of management. In: Journal of Orthopaedics and Traumatology. 2015 ; Vol. 16, No. 2. pp. 81-86.
@article{515bacac8ce94cf1820c171d1af43bec,
title = "Bone metastases of unknown origin: epidemiology and principles of management",
abstract = "Abstract: Metastases are the most common malignancies involving bone; breast, prostate, lung and thyroid are the main sites of primary cancer. However, up to 30 {\%} of patients present with bone metastases of unknown origin, where the site of the primary neoplasm cannot be identified at the time of diagnosis despite a thorough history, physical examination, appropriate laboratory testing and modern imaging technology (CT, MRI, PET). Sometimes only extensive histopathological investigations on bone specimens from biopsy can suggest the primary malignancy. At other times, a bone lesion can have such a highly undifferentiated histological appearance that a precise pathological classification on routine hematoxylin–eosin-stained section is not possible. The authors reviewed the relevant literature in an attempt to investigate the epidemiology of the histological primaries finally identified in patients with bone metastases from occult cancer, and a strategy of management and treatment of bone metastases from occult carcinomas is suggested. Lung, liver, pancreas and gastrointestinal tract are common sites for primary occult tumors. Adenocarcinoma is the main histological type, accounting for 70 {\%} of all cases, while undifferentiated cancer accounts for 20 {\%}. Over the past 30 years, lung cancer is the main causative occult primary for bone metastases and has a poor prognosis with an average survival of 4–8 months. Most relevant literature focuses on the need for standardized diagnostic workup, as surgery for bone lesions should be aggressive only when they are solitary and/or the occult primaries have a good prognosis; in these cases, identification of the primary tumor may be important and warrants special diagnostic efforts. However, in most cases, the primary site remains unknown, even after autopsy. Thus, orthopedic surgery has a mainly palliative role in preventing or stabilizing pathological fractures, relieving pain and facilitating the care of the patient in an attempt to provide the most appropriate therapy for the primary tumor as soon as possible. Level of evidence: 5",
keywords = "Bone metastases, Carcinoma, Unknown origin",
author = "Andrea Piccioli and Giulio Maccauro and Spinelli, {Maria Silvia} and Roberto Biagini and Barbara Rossi",
year = "2015",
month = "3",
day = "1",
doi = "10.1007/s10195-015-0344-0",
language = "English",
volume = "16",
pages = "81--86",
journal = "Journal of Orthopaedics and Traumatology",
issn = "1590-9921",
publisher = "Springer-Verlag Italia",
number = "2",

}

TY - JOUR

T1 - Bone metastases of unknown origin

T2 - epidemiology and principles of management

AU - Piccioli, Andrea

AU - Maccauro, Giulio

AU - Spinelli, Maria Silvia

AU - Biagini, Roberto

AU - Rossi, Barbara

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Abstract: Metastases are the most common malignancies involving bone; breast, prostate, lung and thyroid are the main sites of primary cancer. However, up to 30 % of patients present with bone metastases of unknown origin, where the site of the primary neoplasm cannot be identified at the time of diagnosis despite a thorough history, physical examination, appropriate laboratory testing and modern imaging technology (CT, MRI, PET). Sometimes only extensive histopathological investigations on bone specimens from biopsy can suggest the primary malignancy. At other times, a bone lesion can have such a highly undifferentiated histological appearance that a precise pathological classification on routine hematoxylin–eosin-stained section is not possible. The authors reviewed the relevant literature in an attempt to investigate the epidemiology of the histological primaries finally identified in patients with bone metastases from occult cancer, and a strategy of management and treatment of bone metastases from occult carcinomas is suggested. Lung, liver, pancreas and gastrointestinal tract are common sites for primary occult tumors. Adenocarcinoma is the main histological type, accounting for 70 % of all cases, while undifferentiated cancer accounts for 20 %. Over the past 30 years, lung cancer is the main causative occult primary for bone metastases and has a poor prognosis with an average survival of 4–8 months. Most relevant literature focuses on the need for standardized diagnostic workup, as surgery for bone lesions should be aggressive only when they are solitary and/or the occult primaries have a good prognosis; in these cases, identification of the primary tumor may be important and warrants special diagnostic efforts. However, in most cases, the primary site remains unknown, even after autopsy. Thus, orthopedic surgery has a mainly palliative role in preventing or stabilizing pathological fractures, relieving pain and facilitating the care of the patient in an attempt to provide the most appropriate therapy for the primary tumor as soon as possible. Level of evidence: 5

AB - Abstract: Metastases are the most common malignancies involving bone; breast, prostate, lung and thyroid are the main sites of primary cancer. However, up to 30 % of patients present with bone metastases of unknown origin, where the site of the primary neoplasm cannot be identified at the time of diagnosis despite a thorough history, physical examination, appropriate laboratory testing and modern imaging technology (CT, MRI, PET). Sometimes only extensive histopathological investigations on bone specimens from biopsy can suggest the primary malignancy. At other times, a bone lesion can have such a highly undifferentiated histological appearance that a precise pathological classification on routine hematoxylin–eosin-stained section is not possible. The authors reviewed the relevant literature in an attempt to investigate the epidemiology of the histological primaries finally identified in patients with bone metastases from occult cancer, and a strategy of management and treatment of bone metastases from occult carcinomas is suggested. Lung, liver, pancreas and gastrointestinal tract are common sites for primary occult tumors. Adenocarcinoma is the main histological type, accounting for 70 % of all cases, while undifferentiated cancer accounts for 20 %. Over the past 30 years, lung cancer is the main causative occult primary for bone metastases and has a poor prognosis with an average survival of 4–8 months. Most relevant literature focuses on the need for standardized diagnostic workup, as surgery for bone lesions should be aggressive only when they are solitary and/or the occult primaries have a good prognosis; in these cases, identification of the primary tumor may be important and warrants special diagnostic efforts. However, in most cases, the primary site remains unknown, even after autopsy. Thus, orthopedic surgery has a mainly palliative role in preventing or stabilizing pathological fractures, relieving pain and facilitating the care of the patient in an attempt to provide the most appropriate therapy for the primary tumor as soon as possible. Level of evidence: 5

KW - Bone metastases

KW - Carcinoma

KW - Unknown origin

UR - http://www.scopus.com/inward/record.url?scp=84929706411&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929706411&partnerID=8YFLogxK

U2 - 10.1007/s10195-015-0344-0

DO - 10.1007/s10195-015-0344-0

M3 - Article

AN - SCOPUS:84929706411

VL - 16

SP - 81

EP - 86

JO - Journal of Orthopaedics and Traumatology

JF - Journal of Orthopaedics and Traumatology

SN - 1590-9921

IS - 2

M1 - 344

ER -